⌘K

Login Start Free

Home/Filings/4/0001102624-13-000570

4//SEC Filing

Clerici John 4

Accession 0001102624-13-000570

CIK 0001261734other

View on SEC.gov Company Profile

Filed

May 9, 8:00 PM ET

Accepted

May 10, 7:42 PM ET

Size

5.5 KB

Accession

0001102624-13-000570

Insider Transaction Report

Form 4

Period: 2013-05-08

AEOLUS PHARMACEUTICALS, INC.AOLS

Director

Transactions

Award
Non-qualified Stock Option (right to buy)
2013-05-08+75,000→ 75,000 total
Exercise: $0.44Exp: 2023-05-08→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]Option will vest in equal monthly installments over a period of twelve months from the date of grant, provided that the Director remains on the Board of Directors of the Company.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

AEOLUS PHARMACEUTICALS, INC.

CIK 0001261734

Entity typeother

Related Parties

1

filerCIK 0001576366

Filing Metadata

Form type: 4
Filed: May 9, 8:00 PM ET
Accepted: May 10, 7:42 PM ET
Size: 5.5 KB

View on SEC.gov